Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Double Posteromedial Approach for Treating Posterior Cruciate Ligament Cysts
Published on: October 20, 2023
Lateral Surgical Approach for Subungual Glomus Tumors With Low Recurrence Rates: A Single-Center Case Series
Roberto Martínez-Mejorada1, Gabriel García-González2, Alejandro Curiel-Rivas3
1Plastic and Reconstructive Surgery, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Introduction:
Glomus tumors are rare benign mesenchymal neoplasms typically presenting as small, painful, blue-red nodules with cold sensitivity. Surgical excision with complete removal of the tumor capsule is the standard treatment for benign glomus tumors. Recurrence is uncommon but can occur if the tumor is not fully excised.
Methods:
This retrospective, single-center case series includes a sample of 24 patients with glomus tumors treated surgically between 2017 and 2023 by the Department of Plastic and Reconstructive Surgery at the Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico.
Results:
Glomus tumors were more common in women (n=18, 75%), and affected the left hand in 17 cases (70.8%) and the subungual region in 11 cases (45.8%). The thumb and index digits were the most frequently affected, while the third and fifth were the least. The average duration of symptoms before diagnosis was 2.9 years. A single case had a history of recurrence, in which the participant had been previously treated at another facility before we performed the second resection.
Conclusion:
A lateral surgical approach with careful matriectomy was effective in most cases, with minimal recurrence. The case with previous recurrence underscores the importance of complete excision.
More Related Videos
09:01Treatment of Ankle Osteoarthritis with Total Ankle Replacement Through a Lateral Transfibular Approach
Published on: January 24, 2018
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022